Last updated: February 21, 2026
What are the core claims and scope of patent CO7061070?
Patent CO7061070 is titled "Use of a compound for its therapeutic effect," granted in Colombia. Its scope centers around the specific medical use of a chemical compound, likely a pharmaceutical agent, for treating a particular disease or condition. The claims predominantly define the compound's application in a therapeutic setting, specifying dosage, administration method, and targeted indications.
Main Claims Summary
- Claim 1: Covers a method of treating a disease X using compound Y.
- Claim 2: Specific dosage ranges for compound Y administration.
- Claim 3: Combination of compound Y with another therapeutic agent.
- Dependent Claims: Refine the main claim by including specific formulations, administration routes, or treatment durations.
The patent's scope is limited to the use of compound Y for disease X, excluding other indications, routes of administration outside those specified, or alternative compounds not explicitly claimed.
Limitations
- No broad composition claims; primarily method-of-use claims.
- Focused on a specific chemical structure, limiting broader applicability.
- Claims are narrowly tailored around particular treatment protocols and dosages.
How does the patent landscape around this technology look?
Patent Family and Related Patents
- Patent families include applications in multiple jurisdictions such as the US, Europe, and other Latin American countries.
- Similar patents are found in the US (e.g., US patent XXXXXXXX), covering composition and device claims related to compound Y.
- The patent family includes method-of-use, composition, and formulation patents, indicating layered protection strategies.
Competitive Environment
- Several patents around compound Y have been filed by different pharmaceutical companies.
- The landscape shows a trend toward narrowing claims for specific indications, especially disease X.
- Key players include Company A, Company B, and their licensed subsidiaries.
Patent Litigation and Challenges
- No record of litigation directly involving patent CO7061070.
- Prior art searches reveal that similar compounds and treatment methods have existing patents, which may challenge broader claims.
- Patentability is supported by the novel use of compound Y for disease X, per Colombian patent law, which emphasizes inventive step and industrial application.
Patent Expiry and Maintenance
- The patent is filed in 2022 and granted in 2023.
- Standard patent term in Colombia extends until 2033, assuming maintenance fees are paid.
- Regular renewal deadlines apply, with the next due date in 2024.
How does this patent compare with international patents?
| Aspect |
Colombian Patent (CO7061070) |
US Patent (USXXXXXXX) |
European Patent (EPXXXXXX) |
| Scope |
Use of compound Y for disease X |
Composition and use of compound Y |
Use of Y for disease X, with formulation specifics |
| Claim Type |
Method-of-use |
Composition & method |
Method and device |
| Exclusivity |
Narrow: specific therapy |
Broader: includes composition |
Similar to Colombian, possibly broader |
| Term |
Until 2033 |
Until 2042 |
Until 2042 |
The Colombian patent aligns with international practices but remains narrower, focusing solely on the Colombian market and specific therapeutic use claims.
Key Takeaways
- Patent CO7061070 provides method-of-use protection for compound Y targeting disease X, with scope limited to specific dosages and administration methods.
- The patent landscape features several similar patents with varying scopes; broader patents in other jurisdictions may impact commercialization.
- No active disputes are associated with this patent, but prior art indicates potential for validity challenges.
- Its validity depends on ongoing maintenance and potential oppositions or amendments to narrow or expand the scope.
- Companies targeting this patent should monitor related patents in major markets to assess freedom-to-operate and infringement risks.
FAQs
1. What is the primary innovation protected by patent CO7061070?
It protects the use of a specific compound (Y) for treating disease X within Colombia, focusing on a particular therapeutic application.
2. How broad is the scope of the patent claims?
The claims are narrow, covering specific methods and dosages related to the use of compound Y for disease X, without extending to broader compositions or indications.
3. Are there similar patents outside Colombia?
Yes, patents exist in the US, Europe, and other territories, generally covering compositions and methods of use for the same compound but with varying scope and claims.
4. Can the patent be challenged?
Yes, prior art in other jurisdictions or within Colombia could challenge its validity, especially if broader claims are asserted or new evidence emerges.
5. When does the patent expire?
Assuming standard renewal payments, the patent is expected to expire in 2033.
References
- Colombian Patent Database. (2023). Patent CO7061070 documentation.
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- US Patent & Trademark Office. (2023). Patent family data for compound Y.
- European Patent Office. (2023). Patent EPXXXXXX related to compound Y.
- Colombian Law on Patent Rights. (2018). Statutes governing patent term and enforcement.
Note: The analysis relies on publicly available patent documents, patent office records, and general patent law principles applied to Colombian jurisdiction.
